Cargando…

Recurrent Amplification of the Osmotic Stress Transcription Factor NFAT5 in Adrenocortical Carcinoma

Tumorigenesis requires mitigation of osmotic stress and the transcription factor nuclear factor of activated T cells 5 (NFAT5) coordinates this response by inducing transcellular transport of ions and osmolytes. NFAT5 modulates in vitro behavior in several cancer types, but a potential role of NFAT5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Taylor C, Nicolson, Norman G, Man, Jianliang, Gibson, Courtney E, Stenman, Adam, Juhlin, C Christofer, Korah, Reju, Carling, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304660/ https://www.ncbi.nlm.nih.gov/pubmed/32587934 http://dx.doi.org/10.1210/jendso/bvaa060

Ejemplares similares

Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion
por: Nicolson, Norman G., et al.
Publicado: (2020)

Whole-Exome Sequencing of Syndromic Adrenocortical Carcinoma Reveals Distinct Mutational Profile From Sporadic ACC
por: Nicolson, Norman G, et al.
Publicado: (2019)

A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis
por: Cheng, Joyce Y., et al.
Publicado: (2017)

Gene Expression and Regulation in Adrenocortical Tumorigenesis
por: Fonseca, Annabelle L., et al.
Publicado: (2012)

SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior
por: Brown, Taylor C., et al.
Publicado: (2018)

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
por: Liu, Tiantian, et al.
Publicado: (2014)

Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma
por: Korah, Reju, et al.
Publicado: (2013)

Synchronous aldosterone- and cortisol-producing adrenocortical adenomas diagnosed using CYP11B immunohistochemistry
por: Stenman, Adam, et al.
Publicado: (2019)

Whole‐exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene
por: Juhlin, C. Christofer, et al.
Publicado: (2015)

Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma
por: Rubinstein, Jill C., et al.
Publicado: (2016)

Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas
por: Nolé, Paola, et al.
Publicado: (2016)

Novel Insights in the Genomics of Anaplastic Thyroid Carcinoma: A Role for Cyclin-Dependent Kinase Inhibition?
por: Stenman, Adam, et al.
Publicado: (2023)

Role of NFAT5 in Inflammatory Disorders Associated with Osmotic Stress
por: Neuhofer, Wolfgang
Publicado: (2010)

The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas—A Meta-Analysis and Systematic Review of the Literature
por: Stenman, Adam, et al.
Publicado: (2019)

Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms
por: Stenman, Adam, et al.
Publicado: (2018)

Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature
por: Stenman, Adam, et al.
Publicado: (2022)

Papillary Thyroid Carcinoma with Desmoid-Like Fibromatosis: Double Trouble?
por: Juhlin, C. Christofer, et al.
Publicado: (2022)

Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series
por: Stenman, Adam, et al.
Publicado: (2023)

Mutational Analysis of ZFY in Sporadic Parathyroid Adenomas
por: Romano, Robert, et al.
Publicado: (2017)

PIK3CA Mutational Analysis of Parathyroid Adenomas
por: Riccardi, Aaliyah, et al.
Publicado: (2020)

NFAT5 genes are part of the osmotic regulatory system in Atlantic salmon (Salmo salar)
por: Lorgen, Marlene, et al.
Publicado: (2017)

Presentation, Treatment, Histology, and Outcomes in Adrenal Medullary Hyperplasia Compared With Pheochromocytoma
por: Falhammar, Henrik, et al.
Publicado: (2019)

Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
por: Lebastchi, Amir H., et al.
Publicado: (2012)

Osmotic regulation of NFAT5 expression in RPE cells: The involvement of purinergic receptor signaling
por: Hollborn, Margrit, et al.
Publicado: (2017)

Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report
por: Stenman, Adam, et al.
Publicado: (2021)

TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
por: Solhusløkk Höse, Karolina, et al.
Publicado: (2023)

Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma
por: Stenman, Adam, et al.
Publicado: (2021)

Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics
por: Hysek, Martin, et al.
Publicado: (2019)

Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma
por: Stenman, Adam, et al.
Publicado: (2021)

Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry
por: Juhlin, C. Christofer
Publicado: (2021)

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?
por: Johansson, Klara, et al.
Publicado: (2021)

Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center
por: Hellgren, L. Samuel, et al.
Publicado: (2022)

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
por: Goh, Gerald, et al.
Publicado: (2014)

HRAS mutation prevalence and associated expression patterns in pheochromocytoma
por: Stenman, Adam, et al.
Publicado: (2016)

Current management options for recurrent adrenocortical carcinoma
por: Glover, Anthony R, et al.
Publicado: (2013)

Parafibromin as a Diagnostic Instrument for Parathyroid Carcinoma-Lone Ranger or Part of the Posse?
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

Parathyroid Adenoma With Respiratory-Like Epithelium: Case Report of a Potential Mimic With Unknown Etiology
por: Juhlin, C. Christofer, et al.
Publicado: (2021)

Top 10 Histological Mimics of Neuroendocrine Carcinoma You Should Not Miss in the Head and Neck
por: Juhlin, C. Christofer, et al.
Publicado: (2023)

Distinguishing between thyroid and parathyroid nodules by ultrasound: a potential game-changer in clinical practice?
por: Juhlin, C. Christofer, et al.
Publicado: (2023)

Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation
por: Juhlin, Carl Christofer
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_42fcbtjfod3qjrr8jboguendqi